$203.00
A lab panel designed to evaluate reproductive hormones and ovarian reserve markers that influence fertility, cycle regularity, and reproductive planning. Ideal for women seeking deeper insight into fertility potential or experiencing complex reproductive or hormonal concerns.
Prescription treatments include a short medical intake at checkout. A licensed clinician reviews every order before anything is prescribed or shipped — if it is not approved, you are fully refunded.
Reproductive hormones: Estradiol, progesterone, total testosterone, free testosterone, and DHEA-S
Pituitary signaling: FSH and LH to assess ovarian communication and cycle regulation
Hormone availability: SHBG to understand biologically active hormone levels
Ovarian reserve markers: Anti Müllerian hormone (AMH)
Prolactin: Evaluated for its role in ovulation and cycle disruption
Thyroid function: TSH, free T4, and free T3 to assess metabolic and reproductive support
Nutrient and metabolic support: Vitamin D and ferritin
Cycle timing matters more for this panel than most. Proper timing helps ensure results are interpreted accurately in context.
For fertility-focused testing: schedule your draw during the mid-luteal phase, typically days 19 to 23 of a standard 28-day cycle.
For hormonal transition or perimenopause assessment: schedule your draw during the early follicular phase, typically days 1 to 5 of your cycle.
Cycle timing is not always predictable. You may reschedule your lab appointment if needed, though same-week availability may be limited.
It is recommended to fast for at least 8 hours before your draw.
Why it matters: evaluating sex hormones, pituitary signaling, thyroid, and ovarian reserve together offers a nuanced view of how the hormonal system is functioning and how it may change over time.
Who it's for: especially useful for women actively trying to conceive, planning future fertility, or navigating irregular cycles, unexplained infertility, or possible perimenopause.
Cycle timing matters for this panel: mid-luteal (days 19–23) for fertility-focused testing, or early follicular (days 1–5) for hormonal transition assessment.
It is recommended to fast for at least 8 hours before your draw.
Medications sourced from 503A and 503B U.S.-licensed pharmacies.
Lab testing conducted through CLIA-certified laboratories.
Care delivered by board-certified clinicians.
Available in all 50 states and Washington, D.C.